{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:03:34Z","timestamp":1774667014242,"version":"3.50.1"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"31","license":[{"start":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T00:00:00Z","timestamp":1531785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"name":"RACP Bushells Travelling Fellowship"},{"name":"Early Career Fellowship"},{"name":"National Health and Medical Research Council of Australia"},{"name":"National Health and Medical Research Council of Australia"},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 DK108809"],"award-info":[{"award-number":["U01 DK108809"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,14]]},"DOI":"10.1093\/eurheartj\/ehy344","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T19:11:24Z","timestamp":1527275484000},"page":"2859-2866","source":"Crossref","is-referenced-by-count":40,"title":["Primary prevention implantable cardioverter-defibrillator and opportunities for sudden cardiac death risk assessment in non-ischaemic cardiomyopathy"],"prefix":"10.1093","volume":"39","author":[{"given":"Rajeev K","family":"Pathak","sequence":"first","affiliation":[{"name":"Electrophysiology Section, Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, 9 Founders Pavilion, 3400 Spruce Street, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashanthan","family":"Sanders","sequence":"additional","affiliation":[{"name":"Center for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, University of Adelaide and Royal Adelaide Hospital, North Terrace, Adelaide, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat","family":"Deo","sequence":"additional","affiliation":[{"name":"Electrophysiology Section, Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, 9 Founders Pavilion, 3400 Spruce Street, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,17]]},"reference":[{"key":"key\n\t\t\t\t20180820094401_ehy344-B1","first-page":"e38","article-title":". Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCULATIONAHA.111.023838","article-title":"Epidemiology and genetics of sudden cardiac death","volume":"125","author":"Deo","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B3","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B6","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"Jama"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT)","volume":"105","author":"Bansch","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B8","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2013AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B9","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B10","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/CIRCULATIONAHA.117.028829","article-title":"Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure","volume":"136","author":"Elming","year":"2017","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B11","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jchf.2016.02.019","article-title":"Lessons learned and insights gained in the design, analysis, and outcomes of the COMPANION trial","volume":"4","author":"Bristow","year":"2016","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B13","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehl099","article-title":"Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B14","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.jacc.2017.01.042","article-title":"Adding defibrillation therapy to cardiac resynchronization on the basis of the myocardial substrate","volume":"69","author":"Barra","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B15","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","author":"Al-Khatib","year":"2017","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.116.026056","article-title":"Implantable cardioverter-defibrillator for nonischemic cardiomyopathy: an updated meta-analysis","volume":"135","author":"Golwala","year":"2017","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamacardio.2017.0630","article-title":"Primary prevention implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy: a meta-analysis","volume":"2","author":"Al-Khatib","year":"2017","journal-title":"JAMA Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMc1614441","article-title":"ICD implantation in patients with nonischemic heart failure","volume":"376","author":"Fauchier","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7326\/M17-0120","article-title":"Implantable cardioverter-defibrillators for primary prevention in patients with ischemic or nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"167","author":"Kolodziejczak","year":"2017","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Shen","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B22","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B23","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.109.853689","article-title":"Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial","volume":"120","author":"Packer","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B24","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.110.976092","article-title":"Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop","volume":"122","author":"Fishman","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jacc.2008.05.003","article-title":"American Heart Association\/American College of Cardiology Foundation\/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention","volume":"52","author":"Goldberger","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B26","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0195-668X(03)00191-X","article-title":"Out-of-hospital cardiac arrest\u2014the relevance of heart failure. The Maastricht Circulatory Arrest Registry","volume":"24","author":"Gorgels","year":"2003","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B27","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacc.2005.11.045","article-title":"Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study","volume":"47","author":"Stecker","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-147-4-200708210-00007","article-title":"Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction","volume":"147","author":"Ezekowitz","year":"2007","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/CIRCULATIONAHA.108.816884","article-title":"Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population","volume":"120","author":"Levy","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.106.687103","article-title":"Prediction of mode of death in heart failure: the Seattle Heart Failure Model","volume":"116","author":"Mozaffarian","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0735-1097(98)00184-3","article-title":"Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry","volume":"32","author":"Wu","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B32","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2004.01.029","article-title":"Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars","volume":"43","author":"Soejima","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B33","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jacc.2008.11.052","article-title":"Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate","volume":"53","author":"Bogun","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B34","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","article-title":"The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"43","author":"Moon","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B35","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacc.2012.02.070","article-title":"Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation","volume":"60","author":"Klem","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B36","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/europace\/eus104","article-title":"Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy","volume":"14","author":"Fernandez-Armenta","year":"2012","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/hrt.2010.205542","article-title":"Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy","volume":"97","author":"Lehrke","year":"2011","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B38","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B39","doi-asserted-by":"crossref","first-page":"e004333.","DOI":"10.1161\/CIRCEP.116.004333","article-title":"Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"9","author":"Muser","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","article-title":"Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"7","author":"Kuruvilla","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B41","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCEP.110.959957","article-title":"Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy","volume":"4","author":"Hutchinson","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCEP.114.002145","article-title":"Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation","volume":"8","author":"Kumar","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B44","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCEP.113.000159","article-title":"Impact of nonischemic scar features on local ventricular electrograms and scar-related ventricular tachycardia circuits in patients with nonischemic cardiomyopathy","volume":"6","author":"Sasaki","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B45","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.hrthm.2011.03.008","article-title":"Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications","volume":"8","author":"Haqqani","year":"2011","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccep.2016.10.007","article-title":"Ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia","volume":"9","author":"Pathak","year":"2017","journal-title":"Card Electrophysiol Clin"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B47","doi-asserted-by":"crossref","first-page":"e004328.","DOI":"10.1161\/CIRCEP.116.004328","article-title":"Long-term outcome after catheter ablation of ventricular tachycardia in patients with nonischemic dilated cardiomyopathy","volume":"9","author":"Muser","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B48","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.hrthm.2012.12.029","article-title":"Apical ventricular tachycardia morphology in left ventricular nonischemic cardiomyopathy predicts poor transplant-free survival","volume":"10","author":"Frankel","year":"2013","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.73.4.645","article-title":"Endocardial catheter mapping in patients in sinus rhythm: relationship to underlying heart disease and ventricular arrhythmias","volume":"73","author":"Cassidy","year":"1986","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B50","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1046\/j.1460-9592.2002.01114.x","article-title":"Characterization of the electroanatomic substrate for monomorphic ventricular tachycardia in patients with nonischemic cardiomyopathy","volume":"25","author":"Hsia","year":"2002","journal-title":"Pacing Clin Electrophysiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B51","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.0000083725.72693.EA","article-title":"Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia","volume":"108","author":"Hsia","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B52","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jelectrocard.2015.08.028","article-title":"Non-invasive cardiac mapping in clinical practice: application to the ablation of cardiac arrhythmias","volume":"48","author":"Dubois","year":"2015","journal-title":"J Electrocardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B53","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.hrthm.2005.08.019","article-title":"Electrocardiographic imaging (ECGI), a novel diagnostic modality used for mapping of focal left ventricular tachycardia in a young athlete","volume":"2","author":"Intini","year":"2005","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B54","doi-asserted-by":"crossref","first-page":"98ra84.","DOI":"10.1126\/scitranslmed.3002152","article-title":"Noninvasive electroanatomic mapping of human ventricular arrhythmias with electrocardiographic imaging","volume":"3","author":"Wang","year":"2011","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B55","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jelectrocard.2006.03.012","article-title":"Noninvasive electrocardiographic imaging of cardiac resynchronization therapy in patients with heart failure","volume":"39","author":"Rudy","year":"2006","journal-title":"J Electrocardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B56","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2013.01.093","article-title":"Noninvasive electrocardiographic mapping to improve patient selection for cardiac resynchronization therapy: beyond QRS duration and left bundle branch block morphology","volume":"61","author":"Ploux","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B57","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies","volume":"52","author":"Pasotti","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00109-004-0589-1","article-title":"Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A\/C mutations portend a high risk of sudden death?","volume":"83","author":"van Berlo","year":"2005","journal-title":"J Mol Med"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMc052632","article-title":"Primary prevention of sudden death in patients with lamin A\/C gene mutations","volume":"354","author":"Meune","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B60","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","article-title":"Outcome in phospholamban R14del carriers: results of a large multicentre cohort study","volume":"7","author":"van Rijsingen","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B61","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1399-0004.2010.01512.x","article-title":"Desmin-related myopathy","volume":"80","author":"van Spaendonck-Zwarts","year":"2011","journal-title":"Clin Genet"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B62","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2010.09.084","article-title":"SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism","volume":"57","author":"McNair","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B63","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.jacc.2011.01.015","article-title":"Update 2011: clinical and genetic issues in familial dilated cardiomyopathy","volume":"57","author":"Hershberger","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B64","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0735-1097(02)02954-6","article-title":"Natural history of dilated cardiomyopathy due to lamin A\/C gene mutations","volume":"41","author":"Taylor","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B65","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B66","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/eurheartj\/ehv387","article-title":"Approach to family screening in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"37","author":"Te Riele","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B67","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCEP.113.001705","article-title":"Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD)","volume":"7","author":"Cheng","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B68","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/CIRCULATIONAHA.116.023042","article-title":"Development and validation of a sudden cardiac death prediction model for the general population","volume":"134","author":"Deo","year":"2016","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B69","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2016.5951","article-title":"Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease","volume":"315","author":"Ganz","year":"2016","journal-title":"Jama"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B70","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.116.021803","article-title":"Aptamer-based proteomic profiling reveals novel candidate biomarkers and pathways in cardiovascular disease","volume":"134","author":"Ngo","year":"2016","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B71","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/CIRCULATIONAHA.116.025446","article-title":"Emerging affinity-based proteomic technologies for large-scale plasma profiling in cardiovascular disease","volume":"135","author":"Smith","year":"2017","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B72","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0735-1097(89)90093-4","article-title":"Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group","volume":"14","author":"Gradman","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B73","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0002-8703(88)90728-4","article-title":"Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants","volume":"116","author":"Hofmann","year":"1988","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B74","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(94)91895-3","article-title":"Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)","volume":"344","author":"Doval","year":"1994","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B75","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/01.CIR.94.12.3198","article-title":"Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators","volume":"94","author":"Doval","year":"1996","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B76","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/01.CIR.72.3.596","article-title":"Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts","volume":"72","author":"Gardner","year":"1985","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B77","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0002-9149(83)80020-4","article-title":"Relation between late potentials on the body surface and directly recorded fragmented electrograms in patients with ventricular tachycardia","volume":"51","author":"Simson","year":"1983","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B78","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/hc2901.093197","article-title":"Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction","volume":"104","author":"Gomes","year":"2001","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B79","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/S0735-1097(00)01017-2","article-title":"A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification","volume":"36","author":"Gold","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B80","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.CIR.87.4.1083","article-title":"Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy","volume":"87","author":"Mancini","year":"1993","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B81","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/oxfordjournals.eurheartj.a014844","article-title":"Prognostic value of late potentials in patients with congestive heart failure","volume":"17","author":"Galinier","year":"1996","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B82","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1161\/01.CIR.99.10.1385","article-title":"Mechanism linking T-wave alternans to the genesis of cardiac fibrillation","volume":"99","author":"Pastore","year":"1999","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B83","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jacc.2005.03.059","article-title":"Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis","volume":"46","author":"Gehi","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B84","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.0000100721.52503.85","article-title":"Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study","volume":"108","author":"Grimm","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180820094401_ehy344-B85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(03)13865-2","article-title":"T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation","volume":"362","author":"Hohnloser","year":"2003","journal-title":"Lancet"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/39\/31\/2859\/25515579\/ehy344.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T06:28:44Z","timestamp":1661322524000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/39\/31\/2859\/5055243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,17]]},"references-count":85,"journal-issue":{"issue":"31","published-online":{"date-parts":[[2018,7,17]]},"published-print":{"date-parts":[[2018,8,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehy344","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8,14]]},"published":{"date-parts":[[2018,7,17]]}}}